FOR ANIMAL USE ONLY
BRAVECTO® SPOT-ON
INDICATIONS
For the treatment and prevention of tick, flea and mite infestations in dogs and cats.
Bravecto® Spot-On can be used as part of a treatment strategy for Flea Allergy Dermatitis (FAD).
For the treatment of mange caused by Demodex spp. and Sarcoptes scabiei mites in dogs.
For the treatment of Otodectes spp. mite infestations in dogs and cats.
In cats, Bravecto® Spot-On provides immediate and persistent flea and tick killing activity for 3 months.
In dogs, Bravecto® Spot-On provides immediate and persistent tick killing activity for 4 months and flea killing activity for 6 months.
Bravecto® Spot-On is well tolerated in MDR1 dogs. A single treatment prevents Dipylidium caninum transmission from infected fleas to susceptible dogs for 12 weeks.